CTIS2023-505116-37-00进行中(未招募)1 期
Exploratory evaluation of the effect of cholestyramine on serum levels of persistent organic pollutants in obese patients - 21-AOI-07
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64(—)
入选标准
- •Female patients with an accepted indication for bariatric surgery (BMI > 40 kg/m2 or BMI > 35 kg/m2 with complication(s) improveable by surgery), Aged between 18 and 45 years, Having effective contraception (oral contraception, hormonal or non-hormonal intrauterine device, progestin implant) which will be adapted in the peri-operative period in accordance with the recommendations in force
排除标准
- •Pregnant or breastfeeding women, Known allergy or intolerance to cholestyramine, Chronic constipation, Chronic disease that may interfere with the efficacy of treatment (unbalanced diabetes with HbA1c >7%, known and treated dyslipidaemia, chronic renal failure with GFR <60 ml/min, hepatocellular failure), Phenylketonuria, Patients on anti-vitamin K, digoxin, levothyroxine or likely to be on such therapy within 3 months of inclusion.
研究者
相似试验
已完成
不适用
Clinical study of the correlation between cholesterol absorption and coronary risk factors or arteriosclerotic diseases, and of the clinical significance of the controlling cholesterol absorption.HypercholesterolemiaJPRN-UMIN000001718eurology, Respirology, Endocrinology and Metabolism, Miyazaki Medical College, University of Miyazaki200
尚未招募
不适用
ASSESSMENT OF CLINICAL EFFECTS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITION WITH EVACETRAPIB IN PATIENTS AT A HIGH-RISK FOR VASCULAR OUTCOMES- THE ACCELERATE STUDYPER-111-12ELI LILLY AND COMPANY,
招募中
不适用
The clinical study of correlation between cholesterol-lowering therapy and the progression of atherosclerosis in type 2 diabetes mellitusJPRN-UMIN000015925Human Ethics Review Committee of Kumamoto University200
撤回
不适用
Effects of cholestasis on pharmacokineticsicterusjaundice10019654NL-OMON38889Academisch Medisch Centrum15
已完成
不适用
Investigation for the effect of anti-dyslipidemic drugs on serum level of trans-fatty acidsdyslipidemiaJPRN-UMIN000026984Kobe University Graduate School of Medicine40
